Privium Fund Management (UK)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,984
Closed -$1.28M 17
2024
Q2
$1.28M Buy
+13,984
New +$1.3M 0.5% 49
2024
Q1
Sell
-7,645
Closed -$726K 91
2023
Q4
$726K Buy
+7,645
New +$714K 0.49% 47

Other funds holding AMED

Privium Fund Management (UK)'s AMED Position: Q3 2024 in Review

Privium Fund Management (UK) sold out of Amedisys (AMED) in Q3 2024, closing a stake of 13,984 shares — an estimated $1.28M sold.

Privium Fund Management (UK) first reported a position in AMED in Q4 2023 and held it in 2 quarters. The position peaked at $1.28M in Q2 2024. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Privium Fund Management (UK) reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Privium Fund Management (UK) sold 13,984 Amedisys shares in Q3 2024, an estimated $1.28M.
  • Privium Fund Management (UK) first reported a position in Amedisys in Q4 2023 and held it in 2 quarters.
  • Privium Fund Management (UK)'s Amedisys position peaked at $1.28M in Q2 2024.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2024, filed 5 Nov 2024.